На информационном ресурсе применяются рекомендательные технологии (информационные технологии предоставления информации на основе сбора, систематизации и анализа сведений, относящихся к предпочтениям пользователей сети "Интернет", находящихся на территории Российской Федерации)

E-Finance News

25 подписчиков

How Gilead Avoids Billions in U.S. Taxes on Its $1,000-a-Pill Drug

Gilead Sciences Inc., whose $1,000-a-pill hepatitis C treatment is one of the world’s most expensive drugs, is avoiding billions of dollars in U.S. taxes by booking profits overseas.

Opinion:

Michelle the Economist 

There is absolutely nothing wrong with Gilead seeking to legally minimize taxes through their international operations. Congress needs to realize that as long as the US has the highest corporate tax rate in the world at 35%, companies will look for every legal opportunity to do business in other lower tax countries like Ireland where the tax rate is 12.5%. It's not different than Tiger Woods moving from CA where the tax rate is 13.3%, to FL where the tax rate is 0%. Even the US Supreme Court has said there is absolutely nothing wrong with seeking to legally minimize taxes.

And how about some credit to Gilead for developing a Hepatitis C drug which helps large numbers of people?

Картина дня

наверх